| Aspalathin, a dihydrochalcone C-glucoside, protects H9c2 cardiomyocytes againsthigh glucose induced shifts in substrate preference and apoptosis. | Mol Nutr Food Res | 2016 Apr | 26773306 |
| Novel mitochondrial complex I inhibitors restore glucose-handling abilities ofhigh-fat fed mice. | J Mol Endocrinol | 2016 Apr | 26759391 |
| Metformin ameliorates lipotoxicity-induced mesangial cell apoptosis partly viaupregulation of glucagon like peptide-1 receptor (GLP-1R). | Arch Biochem Biophys | 2015 Oct 15 | 26302449 |
| [Mechanisms of action, pharmacology and interactions of dolutegravir]. | Enferm Infecc Microbiol Clin | 2015 Mar | 25858605 |
| Synergistic Effects of a GPR119 Agonist with Metformin on Weight Loss inDiet-Induced Obese Mice. | J Pharmacol Exp Ther | 2015 Jun | 25770135 |
| Metformin reduces the Walker-256 tumor development in obese-MSG rats via AMPK andFOXO3a. | Life Sci | 2015 Jan 15 | 25497710 |
| Effect of bariatric surgery combined with medical therapy versus intensivemedical therapy or calorie restriction and weight loss on glycemic control inZucker diabetic fatty rats. | Am J Physiol Regul Integr Comp Physiol | 2015 Feb 15 | 25540099 |
| Investigating and targeting chronic lymphocytic leukemia metabolism with thehuman immunodeficiency virus protease inhibitor ritonavir and metformin. | Leuk Lymphoma | 2015 Feb | 24828872 |
| Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basalinsulin in type 2 diabetes. | Diabetes Care | 2014 Oct | 25011946 |
| Dietary restriction and the pursuit of effective mimetics. | Proc Nutr Soc | 2014 May | 24411076 |